China Shineway Pharmaceutical Group Limited (CSWYY)
USD 18.53
(0.0%)
USD 18.53
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 140.29 Million | 178.13 Million | 120.53 Million | 102.22 Million | 64.66 Million | 93.47 Million |
| Net Income | 136.83 Million | 107.33 Million | 86.31 Million | 42.74 Million | 72.81 Million | 76.45 Million |
| Depreciation & Amortization | 8.5 Million | 8.71 Million | 9.87 Million | 7.12 Million | 7.72 Million | 6.17 Million |
| Deferred income taxes | - | - | -43.29 Million | -33.28 Million | -44.86 Million | - |
| Stock-based compensation | - | - | 34 Thousand | 131 Thousand | 1.08 Million | 4.39 Million |
| Change in working capital | -13.21 Million | 43.05 Million | 6.69 Million | 5.51 Million | -34.28 Million | -9.11 Million |
| Other non-cash items | 75.23 Million | 19.02 Million | 60.91 Million | 79.99 Million | 62.19 Million | 53.93 Million |
| Investing Cash Flow | -16.01 Million | -17.17 Million | 2.98 Million | -13.05 Million | -3.97 Million | 47 Thousand |
| Investments in PPE | -20.37 Million | -19.22 Million | -14.51 Million | -9.56 Million | -13.22 Million | -21.12 Million |
| Acquisitions | 1.82 Million | 519.62 Thousand | 14.1 Million | -16.07 Million | 46.16 Thousand | 98.38 Thousand |
| Investment purchases | -73.39 Million | -44.55 Million | -57.37 Million | -361.46 Million | -130.24 Million | -62.83 Million |
| Sales/Maturities of investments | 74.88 Million | 45.54 Million | 58.77 Million | 367.96 Million | 135.53 Million | 71.1 Million |
| Other Investing Activities | 1.04 Million | 544.57 Thousand | 1.99 Million | 6.08 Million | 3.92 Million | 12.8 Million |
| Financing Cash Flow | -3.4 Million | -37.03 Million | -128.29 Million | -45.31 Million | -14.27 Million | -85.45 Million |
| Debt repayment | -42.34 Million | -1.11 Million | -57.26 Million | -4.21 Million | -57.65 Million | - |
| Dividends payments | -44.78 Million | -35.89 Million | -70.25 Million | -34.98 Million | -36.04 Million | -39.47 Million |
| Common Stock Repurchased | - | - | -1.19 Million | -5.27 Million | -35.31 Million | -45.98 Million |
| Common Stock Issuance | - | - | 567.96 Thousand | -36.43 Million | -244.01 Million | -304.25 Million |
| Other Financing Activities | 41.9 Million | -1.14 Million | -155.05 Thousand | 35.59 Million | 358.75 Million | -1.00 |
| Accounts receivables | -41.03 Million | -23.56 Million | -10.38 Million | -13.51 Million | -21.25 Million | -26.74 Thousand |
| Accounts payables | 24.84 Million | 11.89 Million | 8.58 Million | -3.63 Million | -3.42 Million | -2.66 Million |
| Inventory | -33.88 Million | -10.35 Million | -21.72 Million | -1.76 Million | -3.66 Million | -18.93 Million |
| Other working capital | 36.85 Million | 65.07 Million | 30.22 Million | 24.42 Million | -5.95 Million | 12.51 Million |
| Cash at beginning of period | 725.93 Million | 659.89 Million | 648.79 Million | 566.56 Million | 528.44 Million | 549.1 Million |
| Cash at end of period | 830.31 Million | 725.93 Million | 659.89 Million | 648.79 Million | 566.56 Million | 528.44 Million |
| Capital Expenditure | -20.37 Million | -19.22 Million | -14.51 Million | -9.56 Million | -13.22 Million | -21.12 Million |
| Effect of forex changes on cash | 6.15 Million | 6.32 Million | -6.51 Million | -6.18 Million | 2.29 Million | -985 Thousand |
| Net cash flow / Change in cash | 104.38 Million | 66.04 Million | 11.09 Million | 82.22 Million | 38.11 Million | -20.65 Million |
| Free Cash Flow | 119.92 Million | 158.9 Million | 106.02 Million | 92.65 Million | 51.43 Million | 72.34 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 86.82 Million | 136.83 Million | 66.04 Million | 70.9 Million | 107.33 Million | 56.08 Million |
| Depreciation & Amortization | 11.18 Million | 8.5 Million | 12.57 Million | 12.42 Million | 8.71 Million | 13.17 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -13.21 Million | - | - | 43.05 Million | - |
| Other non-cash items | -2.66 Million | 75.23 Million | 34.16 Million | -8.79 Million | 19.02 Million | 55.66 Million |
| Investing Cash Flow | -6.52 Million | -16.01 Million | -4.65 Million | -11.02 Million | -17.17 Million | -7.67 Million |
| Investments in PPE | -10.32 Million | -20.37 Million | -3.28 Million | -16.65 Million | -19.22 Million | -8.63 Million |
| Acquisitions | 359.63 Thousand | 1.82 Million | 338.55 Thousand | 1.44 Million | 519.62 Thousand | 382.27 Thousand |
| Investment purchases | -103.93 Million | -73.39 Million | -42.98 Million | -28.85 Million | -44.55 Million | -19.81 Million |
| Sales/Maturities of investments | 107.35 Million | 74.88 Million | 40.93 Million | 32.36 Million | 45.54 Million | 20.23 Million |
| Other Investing Activities | 32.15 Thousand | 1.04 Million | 346.71 Thousand | 679.83 Thousand | 544.57 Thousand | 158.06 Thousand |
| Financing Cash Flow | -41.42 Million | -3.4 Million | -12.37 Million | 9.03 Million | -37.03 Million | -10.62 Million |
| Debt repayment | -4.15 Million | -42.34 Million | -1.83 Million | -43.28 Million | -1.11 Million | - |
| Dividends payments | -45.01 Million | -44.78 Million | -10.04 Million | -33.78 Million | -35.89 Million | -10.14 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -563.63 Thousand | 41.9 Million | -491.79 Thousand | -458.08 Thousand | -1.14 Million | -484.79 Thousand |
| Accounts receivables | - | -41.03 Million | - | - | -23.56 Million | - |
| Accounts payables | - | 24.84 Million | - | - | 11.89 Million | - |
| Inventory | - | -33.88 Million | - | - | -10.35 Million | - |
| Other working capital | - | 36.85 Million | - | - | 65.07 Million | - |
| Cash at beginning of period | 830.31 Million | 725.93 Million | 738.51 Million | 725.93 Million | 659.89 Million | 666.41 Million |
| Cash at end of period | 858.09 Million | 830.31 Million | 830.31 Million | 738.51 Million | 725.93 Million | 725.93 Million |
| Capital Expenditure | -10.32 Million | -20.37 Million | -3.28 Million | -16.65 Million | -19.22 Million | -8.63 Million |
| Effect of forex changes on cash | - | 6.15 Million | - | -0.80 | 6.32 Million | -0.64 |
| Net cash flow / Change in cash | 27.77 Million | 104.38 Million | 91.8 Million | 12.57 Million | 66.04 Million | 59.51 Million |
| Free Cash Flow | 85.01 Million | 119.92 Million | 84.35 Million | 33.03 Million | 158.9 Million | 89.94 Million |
INDFY
267850
FQT
5548
MIN
0YC0